Notable Analyst Rating Changes 05/05: (ARIA) (CRM) (DIS) Upgraded; (SINA) (SFY) (HP) Downgraded
Tweet Send to a Friend
UPGRADES
Jefferies upgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Hold to Buy and moves its price target from $8 to $14 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies upgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Hold to Buy and moves its price target from $8 to $14 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
